New York, NY -- (SBWIRE) -- 01/24/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Triangle Petroleum Corporation (NYSEMKT:TPLM), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Star Scientific, Inc (NASDAQ:STSI), Antares Pharma Inc (NASDAQ:ATRS)
Triangle Petroleum Corporation (NYSEMKT:TPLM) showed a volume of 1.84 million shares by the end of last trade whereas the average volume of the stock remained 1.82 million shares. The stock opened the session at $8.90 but then moved to $8.50. At that price, the stock showed a negative performance of -4.28%. Triangle Petroleum Corporation (Triangle) is an exploration and production company ,which is focused on the development of unconventional shale oil and natural gas resources in the Bakken Shale and Three Forks formations in the Williston Basin of North Dakota and Montana.
Will TPLM Get Buyers Even After The Recent Rally? Find Out Here
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) opened the session at $7.98 and closed the session at $7.84. The stock showed a negative performance of -1.88% in previous trading session. Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France.
Has IDIX Found The Bottom And Ready To Gain Momentum? Find Out Here
Star Scientific, Inc (NASDAQ:STSI) opened the session at $0.91 and closed the session at $0.906. The stock showed a negative performance of -2.06% in previous trading session. The beta of the stock remained 2.35. Star Scientific, Inc. (Star Scientific) is engaged in the manufacturing and production of dietary supplements. The Company’s operating subsidiaries manufacture, distribute and sell consumer products and dietary supplements. Its segment includes dietary supplements.
Why Should Investors Buy STSI After the Recent Fall? Just Go Here and Find Out
Antares Pharma Inc (NASDAQ:ATRS) the stock decreased -1.25% and finished the session at $4.73. Traded with volume of 1.82 million shares in the prior session and the average volume of the stock remained 1.51 million shares. The beta of the stock remained 0.14. Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products.
Will ATRS Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)